Why is Kwality Pharma falling/rising?

As of 14-Jul, Kwality Pharmaceuticals Ltd is currently priced at Rs 1,175.95, reflecting a decrease of Rs 6.0 or 0.51%. Today's price summary indicates that the stock has underperformed its sector by 1.41% and has experienced a trend reversal after two consecutive days of gains, touching an intraday low of Rs 1,140.5, which is a decline of 3.51%. Despite this recent dip, the stock has shown strong performance over various periods, with a 1-year return of 135.66% and a remarkable 5-year return of 3,259.86%. The company has positive financial indicators, such as a low Debt to EBITDA ratio of 1.03 times and a significant net profit growth of 241.51%. However, concerns about poor long-term growth due to a decline in net sales and operating profit over the past five years may be contributing to the stock's recent price movement.
In the broader market context, Kwality Pharmaceuticals has outperformed the Sensex over the past week, with a return of 1.20% compared to the Sensex's decline of 1.42%. This indicates that while the stock is currently facing a short-term setback, it has maintained a strong performance relative to the market in the near term. The stock's liquidity remains adequate, but falling investor participation, as evidenced by a decrease in delivery volume, may signal caution among investors. Additionally, the lack of domestic mutual fund investment could reflect a lack of confidence in the stock's valuation, despite its impressive historical returns.